This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Professor Prithwish Banerjee appointed as National Cardiovascular Disease Lead for the NIHR

A Consultant Cardiologist from Coventry will be promoting opportunities for patients, service users, carers and clinicians to become involved in research, after being appointed National Institute of Health and Care Research (NIHR) National Cardiovascular Disease Specialty Lead.

In addition to practising as a Consultant Cardiologist at University Hospitals Coventry & Warwickshire, Professor Banerjee is Honorary Professor of Cardiology at Warwick Medical School and Coventry University.

The main aim of his new role at the NIHR is to ensure that opportunities to take part in research are offered to all, throughout  their engagement with health and social care. 

Professor Banerjee said: “I’m honoured to have been appointed National Specialty Lead in Cardiovascular Disease, having served as Cardiovascular Lead for the CRN West Midlands (CRN WM) since 2014. I look forward to raising the profile of our work both regionally and nationally.”

Professor Matthew Brookes, Clinical Director of the NIHR CRN WM added: “We have worked for many years with Professor Banerjee and we are delighted for him and for our region that he will now be leading nationally on this vital area of research.”

About Professor Banerjee

Professor  Banerjee trained in cardiology in the Yorkshire (Leeds) Deanery and obtained his accreditation in Cardiology and General Internal Medicine in 2004. He was appointed as Consultant Cardiologist at  University Hospitals Coventry & Warwickshire in November 2004 to establish and lead the heart failure service. 

He was appointed Honorary Professor of Cardiology by Coventry University in May 2016 and by Warwick Medical School in 2019. He is a fellow of the Royal College of Physicians and the European Society of Cardiology. 

His research interests include Heart Failure with preserved ejection fraction (HFpEF), myocardial fatigue, vascular resistance in heart failure, cardiogenic shock, cardiorenal disease and electrical muscle stimulation of the legs for cardiac rehabilitation. Find out more on his website.


For further information contact:  Claire Hall, Communications Lead on 07775 800227.